CategoryBiometric wearables
Overview
Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression. Its Motif BCI XCS System is a wirelessly-powered implant delivering electrical stimulation to brain circuits linked to depression. FDA approved its first clinical trial (RESONATE) in April 2026, making Motif the fastest implantable BCI company from founding to IDE approval.
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- None on file
Key facts
FDA
Indication
Program
Origin
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Motif Neurotech on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Jun 2024. Explore where Motif Neurotech's robots are operating, by place and type.
Relationships
Current leadership (2)
- Sameer Sheth Co-foundersecondary-verified
- Jacob Robinson CEO & Co-foundersecondary-verified
Founders (2)
- Jacob Robinsoncofounderfounded 2023-01-01
- Sameer Shethcofounderno longer at company
Safety record
No incidents on record for Motif Neurotech.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- Motif Neurotech2 deployments
Recent coverage
Motif Neurotech in third-party press
Peer companies
- Google12 models
- Samsung Electronics6 models
- Abbott2 models
- Butterfly Network2 models
- Apple1 model
- Blackrock Neurotech1 model
Mentioned on (2)
Registry pages whose text names Motif Neurotech.
People (2)
Financial state
- Total funding
- $18.8M
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series A2024-01-24
$19M(reported)
Timeline
Every recorded move in Motif Neurotech’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundSeries A funding round
2024-01-24Series A raising $18750000
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 8, 2026
Added to the verified registry
- Deployment recordedJun 1, 2024
Motif BCI at United States
- Deployment recordedJun 1, 2024
Motif BCI at Germany, Europe
Sources (1)
Common questions
What is Motif Neurotech?
What does Motif Neurotech make?
Is Motif Neurotech publicly traded?
Who competes with Motif Neurotech?
Who is the CEO of Motif Neurotech?
How can I invest in Motif Neurotech?
Where is Motif Neurotech headquartered?
How much funding has Motif Neurotech raised?
Who owns Motif Neurotech?
Where does Motif Neurotech operate robots?
How many robots has Motif Neurotech deployed?
Is Motif Neurotech a top robotics company?
When was Motif Neurotech founded?
Is Motif Neurotech safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Motif Neurotech.Peer companies
- Google12 models
- Samsung Electronics6 models
- Abbott2 models
- Butterfly Network2 models
- Apple1 model
- Blackrock Neurotech1 model
In the press
Recent coverage mentioning Motif Neurotech from third-party publications. Automatically surfaced; not part of the verified registry record.
Machine-readable surfaces
- Markdown mirror: /companies/motif-neurotech.md
- RSS feed: /companies/motif-neurotech/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/0cd83b28-d0e9-4f17-be61-c9d20d2b618f
- Revision history: /companies/motif-neurotech/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Google12 models
- Samsung Electronics6 models
- Abbott2 models
- Butterfly Network2 models
- Apple1 model
- Blackrock Neurotech1 model
Video
#depression #braincomputerinterface #neuroscience Nick Halper is the COO of Motif Neurotech a mental health company providing miniaturized, simple, neural implants to help treat disorders such as treatment resistant d
@owlstonemedical6364 @virtuososurgical7377 @MotifNeurotech @biobotsurgicalpteltd7571 @biobotsurgicalu.s.459 Hey there, future biomed engineers! Welcome to
Machine poets. ChatGPT fails. Neurological surveillance. Brain implants that treat depression. Is it scary? Cool? Let’s firehose some questions at Duke Law prof
Heat Index
Category contender75/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Motif Neurotech draws attention at the 2nd percentile but verifies reality at the 48th percentile among biometric robots. Hype Gap -46.8, 29th widest among biometric robots.
6-month trend
Analysis
Clean safety record across 2 verified deployments. Limited public visibility and press coverage relative to peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Nov 6, 2026